11 Aug
|
ONE NUCLEUS
|
Australia
11 Aug
ONE NUCLEUS
Australia
Scendea is seeking a highly motivated Principal Consultant (CMC, small molecules experience) to join our global team on a full time basis. The role requires a proven track record in CMC for small molecule drug development, with expertise in process development, scale‑up, regulatory submissions and the pre‑approval lifecycle management of small molecule products.
This is a hybrid position affiliated with UK or Australia offices, with a minimum one day per month in the office.
J-18808-Ljbffr
📌 Principal Cmc Regulatory Strategist Small Molecules Town Of Cambridge (Australia)
🏢 ONE NUCLEUS
📍 Australia